2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow ActoGeniX N.V.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck AG013, Placebo - Oral Mucositis | Phase 1 | Completed | ActoGeniX N.V. | 25 | 2009-09-01 | 2014-01-07 |
| A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis AG011, Placebo - Moderately Active Ulcerative Colitis | Phase 1 / Phase 2 | Completed | ActoGeniX N.V. | 60 | 2008-07-01 | 2009-09-10 |
Colitis, Ulcerative (1) · Stomatitis (1)
Belgium (1) · Canada (1) · Netherlands (1) · Sweden (1) · United States (1)
Annegret Van der Aa, PhD (1) · Barbara A Murphy, MD (1) · Bernard Coulie, MD PhD (1) · Brian Bressler, MD PhD (1) · Curt Tysk, MD PhD (1) · Daan Hommes, MD PhD (1) · Donald Daly, MD PhD (1) · Erik Hertervig, MD PhD (1) · Geert D'Haens, MD PhD (1) · Hillary Steinhart, MD PhD (1) · James Gregor, MD PhD (1) · Martine De Vos, MD PhD (1) · Olivier Dewit, MD PhD (1) · Philippe Vergauwe, MD PhD (1)